| COVID-19–related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids MC Peters, S Sajuthi, P Deford, S Christenson, CL Rios, MT Montgomery, ... American journal of respiratory and critical care medicine 202 (1), 83-90, 2020 | 540 | 2020 |
| Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts MC Peters, KW McGrath, GA Hawkins, AT Hastie, BD Levy, E Israel, ... The Lancet Respiratory Medicine 4 (7), 574-584, 2016 | 469* | 2016 |
| Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations LC Denlinger, BR Phillips, S Ramratnam, K Ross, NR Bhakta, JC Cardet, ... American journal of respiratory and critical care medicine 195 (3), 302-313, 2017 | 421* | 2017 |
| Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction EM Dunican, BM Elicker, DS Gierada, SK Nagle, ML Schiebler, JD Newell, ... The Journal of clinical investigation 128 (3), 997-1009, 2018 | 418 | 2018 |
| Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma MC Peters, ZK Mekonnen, S Yuan, NR Bhakta, PG Woodruff, JV Fahy Journal of Allergy and Clinical Immunology 133 (2), 388-394. e5, 2014 | 418 | 2014 |
| Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes M Battaglia, S Ahmed, MS Anderson, MA Atkinson, D Becker, PJ Bingley, ... Diabetes care 43 (1), 5-12, 2020 | 270 | 2020 |
| Baseline features of the Severe Asthma Research Program (SARP III) cohort: differences with age WG Teague, BR Phillips, JV Fahy, SE Wenzel, AM Fitzpatrick, WC Moore, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (2), 545-554. e4, 2018 | 261 | 2018 |
| Extracellular DNA, neutrophil extracellular traps, and inflammasome activation in severe asthma ME Lachowicz-Scroggins, EM Dunican, AR Charbit, W Raymond, ... American journal of respiratory and critical care medicine 199 (9), 1076-1085, 2019 | 196 | 2019 |
| Alternative splicing of interleukin-33 and type 2 inflammation in asthma ED Gordon, LJ Simpson, CL Rios, L Ringel, ME Lachowicz-Scroggins, ... Proceedings of the National Academy of Sciences 113 (31), 8765-8770, 2016 | 166 | 2016 |
| Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids MC Peters, S Kerr, EM Dunican, PG Woodruff, ML Fajt, BD Levy, E Israel, ... Journal of Allergy and Clinical Immunology 143 (1), 104-113. e14, 2019 | 160 | 2019 |
| New-onset asthma among soldiers serving in Iraq and Afghanistan AM Szema, MC Peters, KM Weissinger, CA Gagliano, JJ Chen Allergy and Asthma Proceedings 31 (5), 67, 2010 | 139 | 2010 |
| Multiview cluster analysis identifies variable corticosteroid response phenotypes in severe asthma W Wu, S Bang, ER Bleecker, M Castro, L Denlinger, SC Erzurum, JV Fahy, ... American journal of respiratory and critical care medicine 199 (11), 1358-1367, 2019 | 129 | 2019 |
| Evidence for exacerbation-prone asthma and predictive biomarkers of exacerbation frequency MC Peters, D Mauger, KR Ross, B Phillips, B Gaston, JC Cardet, E Israel, ... American journal of respiratory and critical care medicine 202 (7), 973-982, 2020 | 127 | 2020 |
| Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma MC Peters, SE Wenzel The Lancet 395 (10221), 371-383, 2020 | 126 | 2020 |
| A transcriptomic method to determine airway immune dysfunction in T2-high and T2-low asthma MC Peters, L Ringel, N Dyjack, R Herrin, PG Woodruff, C Rios, ... American journal of respiratory and critical care medicine 199 (4), 465-477, 2019 | 116 | 2019 |
| Obesity alters pathology and treatment response in inflammatory disease SP Bapat, C Whitty, CT Mowery, Y Liang, A Yoo, Z Jiang, MC Peters, ... Nature 604 (7905), 337-342, 2022 | 115 | 2022 |
| Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma MD DeBoer, BR Phillips, DT Mauger, J Zein, SC Erzurum, AM Fitzpatrick, ... BMC pulmonary medicine 18, 1-10, 2018 | 97 | 2018 |
| Natural killer cell–mediated inflammation resolution is disabled in severe asthma MG Duvall, C Barnig, M Cernadas, I Ricklefs, N Krishnamoorthy, ... Science immunology 2 (9), eaam5446, 2017 | 92 | 2017 |
| Use of fractional exhaled nitric oxide to guide the treatment of asthma: an official American Thoracic Society clinical practice guideline SB Khatri, JM Iaccarino, A Barochia, I Soghier, P Akuthota, A Brady, ... American journal of respiratory and critical care medicine 204 (10), e97-e109, 2021 | 74 | 2021 |
| Diagnosis and management of T2-high asthma AM Coverstone, MA Seibold, MC Peters The Journal of Allergy and Clinical Immunology: In Practice 8 (2), 442-450, 2020 | 73 | 2020 |
